Breast cancer index (BCI) test
Ended Purchase Order Awarded Last action
- Contract number
- HT001425PE112
- Awardee
-
Biotheranostics Inc. UEI EL5WDRRT6895
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $139,428
Award facts
- Contract value 100% obligated
- $139,428.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $139,428 firm fixed price purchase order to Biotheranostics Inc., a small disadvantaged business specializing in advanced molecular diagnostics and genomic testing services. The contract, which commenced on September 30, 2025 with an ultimate completion date of October 30, 2025, covers Breast Cancer Index (BCI) testing services to be performed at the Bethesda, Maryland location. This award represents a continuation of DHA's precision oncology efforts, providing genomic diagnostic tests that guide cancer treatment planning for military service members and veterans across the Military Health System.
Biotheranostics Inc., a division of Hologic Inc. and registered as a small disadvantaged business since 2000, brings substantial experience delivering cancer diagnostic solutions to federal healthcare providers. The company has previously secured multiple DHA and Veterans Integrated Service Network contracts totaling over $700,000 between 2021–2023, all focused on BCI testing and cancer identification services. This purchase order was issued without a set-aside designation and continues the company's established relationship with DHA in delivering specialized cancer diagnostic capabilities to support military healthcare operations.
Quick answers
Who was awarded contract HT001425PE112?
HT001425PE112 was awarded to Biotheranostics Inc. by Defense Health Agency (Department of Defense) on September 30, 2025.
How much is contract HT001425PE112 worth?
The government has obligated $139,428 on HT001425PE112.
Was contract HT001425PE112 competed?
The extent of competition for HT001425PE112 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award